Dare Bioscience Stock Quote DARE - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.30

Bid

3.30

Ask

3.35

Volume

9,244

3.2582 Day's Range 3.30

3.05 52 Week Range 10.14

Market Cap

26.874M

Previous Close

3.19

Open

3.2582

Last Trade

3.34

Last Trade Time

10:11:05

Financial Volume

$ 30,129

VWAP

3.2593

Average Volume (3m)

649,355

Shares Outstanding

8,424,408

Dividend Yield

PE Ratio

-0.89

Earnings Per Share (EPS)

-3.58

Revenue

2.81M

Net Profit

-30.16M

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve... Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.darebioscience.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Dare Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DARE. The last closing price for Dare Bioscience was $3.19. Over the last year, Dare Bioscience shares have traded in a share price range of $ 3.05 to $ 10.14.

Dare Bioscience currently has 8,424,408 shares outstanding. The market capitalization of Dare Bioscience is $26.87 million. Dare Bioscience has a price to earnings ratio (PE ratio) of -0.89.

Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder

Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.07	-2.07715133531	3.37	3.7377	3.18	37132	3.41704444	CS
4	-1.74	-34.5238095238	5.04	5.76	3.05	257988	4.36849254	CS
12	-0.156	-4.51388888889	3.456	7.56	3.05	649355	4.47440275	CS
26	-0.7284	-18.0816204945	4.0284	7.56	3.05	527602	4.70518141	CS
52	-6.804	-67.3396674584	10.104	10.14	3.05	473253	4.93351392	CS
156	-14.22	-81.1643835616	17.52	30.12	3.05	1260717	18.09460081	CS
260	-6.18	-65.1898734177	9.48	46.2	3.05	1497518	19.68335268	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AUGXAugmedix Inc	$ 2.28 (148.80%)	11.99M
SXTP60 Degrees Pharmaceuticals Inc	$ 0.4486 (82.36%)	137.35M
VRPXVirpax Pharmaceuticals Inc	$ 2.145 (67.58%)	21.18M
SERVServe Robotics Inc	$ 3.9607 (50.60%)	32.78M
AFARUAura FAT Projects Acquisition Corporation	$ 15.24 (31.95%)	6.29k
SPWRSunPower Corporation	$ 0.89985 (-40.41%)	24.66M
HYZNHyzon Motors Inc	$ 0.1796 (-36.76%)	2.65M
KITTNauticus Robotics Inc	$ 0.0925 (-28.24%)	14.08M
SILOSilo Pharma Inc	$ 2.65 (-23.63%)	9.51M
MEDSTRxADE Health Inc	$ 17.61 (-21.45%)	59.03k
SXTP60 Degrees Pharmaceuticals Inc	$ 0.4486 (82.36%)	137.35M
NVDANVIDIA Corporation	$ 120.09 (-0.83%)	39.95M
SQQQProShares UltraPro Short QQQ	$ 8.2701 (0.49%)	33.48M
SERVServe Robotics Inc	$ 3.9607 (50.60%)	32.78M
MAXNMaxeon Solar Technologies Ltd	$ 0.2211 (-8.03%)	30.81M